View in EDS HTML Full Text PDF Full Text

Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022.

Saved in:
Bibliographic Details
Title: Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022.
Authors: Bratcher, Anna1 (AUTHOR) tqx5@cdc.gov, Jones, Jefferson M.2 (AUTHOR), Meyer III, William A.3 (AUTHOR), Waheed, Rehan3 (AUTHOR), Yazgi, Huda3 (AUTHOR), Harris, Aaron4 (AUTHOR), Gundlapalli, Adi V.4 (AUTHOR), Clarke, Kristie E. N.4 (AUTHOR)
Source: PLoS ONE. 1/8/2025, Vol. 20 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0313620